Clinical trials are an important part of acute myeloid leukemia (AML) care at Fred Hutch Cancer Center. Our physicians and researchers continue to study new therapies and treatments for AML. Depending on your diagnosis and treatment plan, you may be eligible to participate in a clinical trial.
Acute Myeloid Leukemia Clinical Trials
Fred Hutch typically has over 750 active cancer clinical trials enrolling participants.
Clinical trials may allow some patients access to a promising new treatment, and help physicians and researchers learn more about a disease.
Research That Advances AML Care
Fred Hutch researchers have helped develop many of today's AML treatments. They continue to lead studies focused on improving care. Current research includes:
- Improved blood and marrow transplant approaches
- New combinations of existing treatments
- New immunotherapies
- New targeted therapies
Our AML Researchers and Faculty
Our scientists and care teams work closely together to prevent, diagnose and treat AML and other diseases. Their laboratory and clinical research helps advance new treatments and improve care for patients. Many of our AML providers are also researchers, bringing the latest scientific discoveries directly into patient care. Through our many AML clinical trials, eligible patients may have access to promising new therapies while helping shape the future of care.
See below for our researchers and faculty or view our AML care team providers.
